<DOC>
	<DOCNO>NCT00634790</DOCNO>
	<brief_summary>The purpose study ass long-term safety tolerability alprazolam extend release ( XR ) adolescents panic disorder , without agoraphobia , anxiety disorder panic attack . Efficacy , population pharmacokinetics alprazolam XR relationship alprazolam XR plasma concentration efficacy outcome also evaluate .</brief_summary>
	<brief_title>A Study To Assess Safety Extended Release Alprazolam Treatment Adolescents With Panic Disorder Anxiety With Panic Attacks</brief_title>
	<detailed_description>Due recruitment difficulty adolescent population , clinical program alprazolam XR cancel study terminate 1 September 2004 . There safety concern lead decision .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Subjects must meet one follow 6 diagnosis : . A current diagnosis panic disorder without agoraphobia ; b. Generalized anxiety disorder history least one panic attack course illness ; c. Social anxiety disorder ( social phobia ) history least one panic attack course illness ; d. Separation anxiety history least one panic attack course illness ; e. Posttraumatic stress disorder history least one panic attack course illness ; f. Anxiety otherwise specify history least one panic attack course illness . Educational level , intelligence , mental condition subject and/or his/her parent ( ) judge investigator sufficient permit adequate inform consent/assent obtain , study procedure comply . Current ( past 6 month ) diagnosis obsessive compulsive disorder , major depressive disorder , dysthymic disorder , alcohol and/or substance dependence . Current ( past 3 month ) diagnosis alcohol and/or substance abuse . Primary diagnosis conduct disorder , oppositional defiant disorder , Attention Deficit Hyperactivity Disorder . Any current past history schizophrenia psychosis ; bipolar disorder cyclothymia ; dementia , delirium organic brain disease ; eat disorder ; mental retardation , Asperger 's disorder , serious developmental disorder . A Childhood Depression Rating Scale , Revised score &gt; 35 .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>